Category Archives: WHO

WHO Launches Campaign to Combat Antimicrobial Resistance; Most Countries Fail to Report Aggregate Drug Use

Source: Health Policy Watch 19th June, 2019   The World Health Organization (WHO) today launched a global AWaRe campaign, which aims to support national health systems to make more judicious use of lifesaving drugs so as to combat a worldwide trend of … Continue reading

Posted in Antimicrobial Resistance, WHO | Leave a comment

WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72

Source: Health Policy Watch 4th June, 2019   In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new … Continue reading

Posted in WHO | Leave a comment

UK government refuses to sign up to WHO pricing transparency resolution

Source: Pharmafile 4th June, 2019     The UK government has refused to sign up to a global resolution on transparency in drug pricing which urges governments to share information on the prices they pay for drugs. The draft resolution would … Continue reading

Posted in Price Transparency, Transparency, WHO | Leave a comment

Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly

Source: Health Policy 24th May, 2019   The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled … Continue reading

Posted in Drug prices, World Health Assembly | Leave a comment

WHO drug pricing talks may fail to end secrecy, activists fear

Source: Reuters 24th May, 2019   GENEVA (Reuters) – Governments are working on a drug pricing transparency deal at the World Health Organization’s (WHO) annual assembly, but activists said on Thursday they fear crucial costs may be left out, enabling pharmaceutical … Continue reading

Posted in Drug prices, WHO | Leave a comment

Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event

Source: Health Policy Watch 21st May, 2019   The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of … Continue reading

Posted in Drug prices, Price Transparency, World Health Assembly | Leave a comment

Italy submits drug pricing transparency resolution to WHO

21st May, 2019   Improving the transparency of markets for medicines, vaccines, and other healthrelated products and other technologies to be discussed at the 72nd session of the WHA to be held on 20-28 May 2019

Posted in Drug prices, Price Transparency, WHO | Leave a comment